Geoffrey Glass's most recent trade in Avadel Pharmaceuticals plc - ADR was a trade of 10,204 Ordinary Shares done at an average price of $9.8 . Disclosure was reported to the exchange on Dec. 10, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Avadel Pharmaceuticals plc... | Geoffrey Glass | Director | Purchase of securities on an exchange or from another person at price $ 9.80 per share. | 10 Dec 2024 | 10,204 | 75,904 (0%) | 0% | 9.8 | 99,999 | Ordinary Shares |
Avadel Pharmaceuticals plc... | Geoffrey Glass | Director | Purchase of securities on an exchange or from another person at price $ 9.89 per share. | 10 Dec 2024 | 10,075 | 69,075 (0%) | 0% | 9.9 | 99,642 | Ordinary Shares |
Avadel Pharmaceuticals plc... | Geoffrey Glass | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Sep 2024 | 11,000 | 0 | - | - | Stock Option (Right to Buy) | |
Avadel Pharmaceuticals plc... | Geoffrey Glass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 (0%) | 0% | 0 | Ordinary Shares | |
Avadel Pharmaceuticals plc... | Geoffrey Glass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jul 2024 | 11,000 | 11,000 | - | - | Stock Option (Right to Buy) |